AI consulting - Boston

AI consulting in Boston

In Boston the question is almost never whether a model can do the task, it is whether the resulting system can be validated and who is allowed to see the data it reads.

Boston concentrates biotech, hospital systems, medical devices and a very large higher education sector. Both halves of that market buy AI under constraints that most vendors meet for the first time in the middle of a project, which is the expensive place to meet them.

Validation, and the shift toward risk-based assurance

Regulated life sciences companies have to demonstrate that computerised systems used in regulated processes are fit for intended use, with records that hold up on inspection. Guidance has moved toward computer software assurance, which concentrates testing effort where patient safety and product quality risk actually sit, rather than producing uniform documentation for everything. That is good news for AI work if you use it correctly.

The practical approach is to separate the system into risk tiers at design time. A retrieval assistant that helps a scientist find prior protocols is low risk and needs light assurance. A system that touches a batch record, a submission document or a device complaint is high risk and needs full validation with a documented intended use, test evidence, change control and periodic review. Mixing both into one system is what forces the whole thing into the highest tier.

Research data has a second gatekeeper

Human subjects research adds an institutional review board to the path. Introducing a model into a study workflow can change the approved protocol, particularly if identifiable data leaves the institution. The version that clears review keeps identifiable data inside the institutional boundary, sends only de-identified content to any external model, and documents that boundary explicitly. Deciding this after the pilot means re-consenting or restarting.

The university side

Digiton builds and operates production AI agents and closed retrieval systems, with deployments across 8 countries. An AI audit separates the low risk work you can ship this quarter from the validated work that needs a longer path.

Frequently asked questions

What does AI consulting in Boston involve?

Separating candidate work into risk tiers, shipping the low risk internal retrieval quickly, and putting anything that touches a regulated record or a research protocol through the validation and review path it requires. The consulting value is drawing that line early, because mixing tiers forces everything into the strictest one.

Can AI systems be validated for GxP use?

Yes, using a risk-based approach. Define intended use, assess where patient safety and product quality risk actually sits, concentrate testing evidence there, and maintain change control, access control and audit trails. What fails inspection is an undocumented system whose intended use and testing were never written down.

Does using AI in research require IRB review?

It can change an approved protocol, particularly when identifiable data would leave the institution. The safer design keeps identifiable data inside the institutional boundary and sends only de-identified content to any external model, with that boundary documented. Deciding this after a pilot often means re-consenting participants or starting over.

Related

AI SEO in LisbonAI agency in LisbonBook an AI audit

Ready to put AI to work?

Book a discovery audit and we will map the highest-ROI AI agents and automations for your business.

Book a discovery audit →